Wachira John Kelly, Jensen Cristina Hill, Rhone Kelly
Sanford School of Medicine, University of South Dakota, SD, USA.
S D Med. 2013 Jun;66(6):227-9.
Drug-induced pancreatitis (DIP) is a rare problem in medicine. A retrospective study from 45 German centers of gastroenterology concluded that only 22 of 1613 (1.4 percent) cases of acute pancreatitis in 1993 were DIP. Though DIP is a rare etiology of acute pancreatitis compared to other common etiologies like alcohol, gallstones, hypercalcemia, hypertriglyceridemia, infection, trauma or medical procedures like endoscopic retrograde cholangiopancreatography (ERCP), its incidence continues to rise. We report a case of a 21-year-old female with DIP following doxycycline treatment for an upper respiratory infection.
A 21-year-old, otherwise healthy female presented with severe abdominal discomfort associated with nausea and vomiting. She was hemodynamically stable with normal vital signs. Physical exam revealed a soft but tender to palpation epigastric area. Peritoneal signs were negative. Urinalysis was negative for acute infection. Urine human chorionic gonadotrophin was negative for pregnancy. Laboratory findings revealed a mildly elevated lipase level at 128 U/L (normal 13-60) but was otherwise normal. A computed tomography of abdomen and pelvis revealed evidence of fat stranding consistent with acute pancreatitis. A right upper quadrant ultrasound ruled out gallstones. A serum triglyceride was within normal limit at 80mg/dl. She denied any alcohol use. On further questioning, the patient admitted to previously being diagnosed with an upper respiratory infection two weeks earlier. She had consequently finished a 10-day course of doxycycline therapy, with her last dose five days before presentation. After a literature review of drugs implicated in DIP and ruling out other causes of acute pancreatitis, we concluded that our patient had doxycycline-induced pancreatitis. Follow-up visit three weeks post discharge revealed complete resolution of previous symptoms.
In our vastly evolving pharmacotherapy world, DIP should be entertained as a possible etiology of idiopathic pancreatitis, especially after other common causes have been ruled out.
药物性胰腺炎(DIP)在医学上是一个罕见问题。一项来自德国45个胃肠病中心的回顾性研究得出结论,1993年1613例急性胰腺炎病例中只有22例(1.4%)是DIP。尽管与酒精、胆结石、高钙血症、高甘油三酯血症、感染、创伤或内镜逆行胰胆管造影术(ERCP)等其他常见病因相比,DIP是急性胰腺炎的罕见病因,但其发病率仍在持续上升。我们报告一例21岁女性在使用强力霉素治疗上呼吸道感染后发生DIP的病例。
一名21岁、其他方面健康的女性因严重腹部不适伴恶心和呕吐就诊。她血流动力学稳定,生命体征正常。体格检查发现上腹部柔软但触诊时有压痛。腹膜刺激征阴性。尿液分析急性感染阴性。尿人绒毛膜促性腺激素妊娠试验阴性。实验室检查结果显示脂肪酶水平轻度升高至128 U/L(正常范围13 - 60),其他指标正常。腹部和盆腔计算机断层扫描显示有与急性胰腺炎相符的脂肪沉积迹象。右上腹超声排除胆结石。血清甘油三酯在正常范围内,为80mg/dl。她否认饮酒。进一步询问时,患者承认两周前曾被诊断为上呼吸道感染。因此,她完成了为期10天的强力霉素治疗疗程,最后一剂在就诊前五天服用。在对与DIP相关的药物进行文献回顾并排除急性胰腺炎的其他病因后,我们得出结论,我们的患者患有强力霉素诱导的胰腺炎。出院后三周的随访显示先前症状完全缓解。
在我们这个药物治疗不断发展的世界中,DIP应被视为特发性胰腺炎的一种可能病因,尤其是在排除其他常见病因之后。